GRAIL 将出席 UBS Global Healthcare Conference
GRAIL to Present at the UBS Global Healthcare Conference
GRAIL 管理层将于 11 月 10 日美国东部时间上午 11:00 在佛罗里达州棕榈滩举行的 UBS Global Healthcare Conference 上进行演讲。网络直播及回放可在 GRAIL 官网投资者关系板块获取，回放至少保留 30 天。GRAIL 是一家专注于通过下一代测序、人群规模临床研究及机器学习实现多种致死性癌症早期检测的医疗公司。
, /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the UBS Global Healthcare Conference in Palm Beach, FL on Tuesday, Nov. 10 at 11:00 a.m. ET.
A live and replay webcast may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Sunnyvale, Calif. with locations in Washington, D.C., North Carolina, and the United Kingdom.
For more information, visit grail.com.
SOURCE GRAIL, Inc.
来源：PR Newswire Health · prnewswire.com